Howard Morris | |
|---|---|
 Morris at the 'Endogenous Opiates' Witness Seminar in November 1995 | |
| Born | Howard Redfern Morris Bolton, Lancashire, United Kingdom |
| Nationality | United Kingdom |
| Occupation | Biochemist |
| Employer | Imperial College |
Howard Redfern Morris FRS is a British biochemist.
He worked at Imperial College as a lecturer from 1975 to 1978, as a Reader in Protein Chemistry from 1978 to 1980, and as Professor (later Emeritus) of Biological Chemistry, from 1980.[1][2]
He is President and CSO, BiopharmaSpec Ltd and serves as a member of the audit committee, of the Institute of Cancer Research.[2]
He was elected a Fellow of the Royal Society in 1988,[2] and in 2014 received the Society's Royal Medal:[2]
For his pioneering work in biomolecular mass spectrometry including strategy and instrument design and for outstanding entrepreneurship in biopharmaceutical characterisation.
References
- ^ Tilli Tansey; Pippa Catterall; Sonia V Willhoft; Daphne Christie; Lois Reynolds, eds. (1997). Technology Transfer in Britain: The Case of Monoclonal Antibodies; Self and Non-Self: A History of Autoimmunity; Endogenous Opiates; The Committee on Safety of Drugs. Wellcome Witnesses to Contemporary Medicine. History of Modern Biomedicine Research Group. ISBN 978-1-869835-79-8. OL 9320034M. Wikidata Q29581528.
- ^ a b c d "Howard Morris". Royal Society. Retrieved 6 June 2017.
External links
- Howard Morris on the History of Modern Biomedicine Research Group website
| Authority control databases: Academics |
|---|
 | This article about a British scientist is a stub. You can help Wikipedia by expanding it. |
This page was last edited on 6 January 2023, at 08:24